Could your blood predict jaw pain? new study investigates cannabinoid receptors

NCT ID NCT06405646

First seen Mar 18, 2026 · Last updated Jun 21, 2026 · Updated 17 times

Summary

This study explores whether the levels of certain receptors (CB1, CB2, TRPV-1) in the blood are linked to chronic orofacial pain from jaw muscles. Researchers will compare 102 adults with and without this pain, using blood tests and clinical exams. The goal is to understand how these receptors, which bind to cannabis-like compounds, might influence pain risk and severity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Wroclaw Medical University

    Wroclaw, 50-425, Poland

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help identify biological markers for chronic orofacial pain, potentially leading to better diagnosis or targeted treatments.

What could go wrong

This is an observational study with only 102 participants, so results may not apply to everyone. It measures receptor levels, not treatments, so direct benefits are uncertain.

Conditions

The condition(s) this trial relates to.

Facial Pain headache disorder Myalgia Tension-Type Headache

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.